Improving Digital Tools for Substance Use Disorder and HIV Prevention and Recovery
Continual Optimization and Personalization of Just-in-Time Adaptive Interventions for SUD Prevention, Treatment, and Recovery
This project is making digital health tools smarter and more personal to help people prevent and recover from substance use disorder and HIV.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11096036 on NIH RePORTER |
What this research studies
We are working to make digital health tools, like mobile apps, much more effective and long-lasting for preventing and treating substance use disorder and HIV. Our approach combines insights from how people behave with advanced artificial intelligence to create tools that can learn and adapt over time. This means the digital interventions will continually improve based on societal changes and also become highly personalized to each individual's changing needs, offering support that feels just right for them.
Who could benefit from this research
Good fit: This research is focused on developing interventions for adults aged 21 and older who are at risk for or living with substance use disorder and HIV.
Not a fit: Patients who do not use digital health technology or prefer traditional in-person care may not directly benefit from this specific digital intervention development.
Why it matters
Potential benefit: If successful, this work could lead to highly effective and personalized digital tools that provide ongoing support for individuals dealing with substance use disorder and HIV.
How similar studies have performed: While digital health interventions exist, this project aims to develop novel methodologies for continual optimization and personalization using advanced AI, representing a new generation of such tools.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Murphy, Susan a — University of Michigan at Ann Arbor
- Study coordinator: Murphy, Susan a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.